The residual cancer burden index as a valid prognostic indicator in breast cancer after neoadjuvant chemotherapy
Số trang: 12
Loại file: pdf
Dung lượng: 1.09 MB
Lượt xem: 5
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
The residual cancer burden index (RCB) was proposed as a response evaluation criterion in breast cancer patients treated with Neoadjuvant Chemotherapy (NAC). This study evaluated the relevance of RCB with replase-free survival (RFS).
Nội dung trích xuất từ tài liệu:
The residual cancer burden index as a valid prognostic indicator in breast cancer after neoadjuvant chemotherapy
Nội dung trích xuất từ tài liệu:
The residual cancer burden index as a valid prognostic indicator in breast cancer after neoadjuvant chemotherapy
Tìm kiếm theo từ khóa liên quan:
BMC Cancer Residual cancer burden Neoadjuvant chemotherapy Breast cancer Pathologic complete response Miller-Payne gradingTài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 171 0 0 -
6 trang 166 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 142 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 120 0 0 -
12 trang 93 0 0
-
19 trang 74 0 0
-
17 trang 64 0 0
-
9 trang 43 0 0
-
12 trang 38 0 0
-
13 trang 38 0 0